Baku 24° C
India’s Covaxin gets WHO approval for emergency use listing
Health
- 03 November, 2021
- 13:42
Bharat Biotech’s Covaxin has got WHO approval as the technical advisory team has recommended the India-made vaccine for emergency use listing for 18 years and above, Report informs referring to Hindustan Times.
This marks a major victory for India’s journey in vaccination against Covid-19.
Covaxin is a vaccine, completely “made in India,” by Hyderabad-based Bharat Biotech and the Indian Council of Medical Research.
The emergency listing got delayed last month as the technical advisory group sought some additional clarification from Bharat Biotech for its final risk assessment.
The technical advisory group met on November 3 to take the final call, and Covaxin has been recommended for emergency use listing.
Author
Latest News
20:51
Photo
Mikayil Jabbarov holds cooperation talks with senior official of US State Department
Economy20:38
Cuba's electrical grid collapses in nationwide blackout
Other countries20:15
Warsaw says Russian drone intrusion 'not an accidental event'
Other countries20:02
MALBI-trans aims increasing volume of European cargo on Middle Corridor - EXCLUSIVE
Business19:52
IDF confirms series of Yemen strikes, say they targeted Houthi military camps
Other countries19:26
Pashinyan: Armenia ready to synchronize TRIPP with Azerbaijan's infrastructure
Region19:16
Death toll in Nepal's Gen-Z protests reaches 30, over 1,000 injured
Other countries19:12
Trump to speak with Polish president after Russian drone incursion: W.House
Other countries18:48
Photo